Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Atresia | 1 | 2023 | 190 | 0.670 |
Why?
|
| Education, Distance | 1 | 2020 | 64 | 0.660 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 500 | 0.590 |
Why?
|
| Echocardiography | 2 | 2020 | 1060 | 0.580 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2009 | 396 | 0.500 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 41 | 0.490 |
Why?
|
| Cardiology | 1 | 2020 | 507 | 0.470 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 171 | 0.460 |
Why?
|
| Clinical Competence | 1 | 2020 | 1001 | 0.430 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 514 | 0.420 |
Why?
|
| Recovery of Function | 1 | 2015 | 443 | 0.420 |
Why?
|
| Cardiac Catheterization | 2 | 2018 | 632 | 0.390 |
Why?
|
| Child Mortality | 1 | 2012 | 24 | 0.390 |
Why?
|
| Heart Ventricles | 2 | 2018 | 777 | 0.380 |
Why?
|
| Aortic Valve Stenosis | 1 | 2015 | 337 | 0.370 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2023 | 160 | 0.330 |
Why?
|
| Melanoma, Experimental | 1 | 2009 | 35 | 0.320 |
Why?
|
| Immunization, Secondary | 2 | 2009 | 104 | 0.320 |
Why?
|
| Vaccinia virus | 1 | 2009 | 52 | 0.310 |
Why?
|
| Smallpox Vaccine | 1 | 2009 | 37 | 0.310 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2009 | 139 | 0.290 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 199 | 0.290 |
Why?
|
| Arterial Switch Operation | 2 | 2018 | 23 | 0.290 |
Why?
|
| Cancer Vaccines | 1 | 2009 | 177 | 0.280 |
Why?
|
| Interferon-gamma | 2 | 2009 | 505 | 0.280 |
Why?
|
| Heart Diseases | 1 | 2012 | 496 | 0.280 |
Why?
|
| HIV | 1 | 2008 | 180 | 0.260 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 471 | 0.260 |
Why?
|
| Hepacivirus | 1 | 2008 | 246 | 0.250 |
Why?
|
| Peptides | 1 | 2009 | 812 | 0.250 |
Why?
|
| Hepatitis C | 1 | 2008 | 366 | 0.220 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1122 | 0.210 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 44 | 0.200 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 179 | 0.200 |
Why?
|
| Child | 8 | 2023 | 24575 | 0.190 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 1719 | 0.180 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 244 | 0.180 |
Why?
|
| HIV Infections | 2 | 2008 | 1894 | 0.150 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2018 | 15 | 0.150 |
Why?
|
| Stroke Volume | 2 | 2023 | 495 | 0.150 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2018 | 56 | 0.140 |
Why?
|
| Purines | 1 | 2018 | 116 | 0.140 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2021 | 282 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 844 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2018 | 306 | 0.120 |
Why?
|
| Curriculum | 1 | 2020 | 726 | 0.120 |
Why?
|
| Female | 7 | 2023 | 66836 | 0.120 |
Why?
|
| Young Adult | 4 | 2021 | 9066 | 0.110 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 804 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3603 | 0.110 |
Why?
|
| ROC Curve | 1 | 2015 | 571 | 0.110 |
Why?
|
| Humans | 11 | 2023 | 125331 | 0.100 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2012 | 20 | 0.100 |
Why?
|
| Child, Preschool | 4 | 2018 | 14123 | 0.100 |
Why?
|
| Male | 6 | 2023 | 61573 | 0.100 |
Why?
|
| Boston | 1 | 2012 | 109 | 0.100 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2012 | 27 | 0.100 |
Why?
|
| Adult | 5 | 2021 | 29607 | 0.090 |
Why?
|
| Infant | 3 | 2018 | 12581 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2020 | 1182 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2018 | 16344 | 0.080 |
Why?
|
| Adolescent | 4 | 2018 | 19419 | 0.080 |
Why?
|
| Cause of Death | 1 | 2012 | 472 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2020 | 6160 | 0.080 |
Why?
|
| Vaccines, Subunit | 1 | 2009 | 66 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 97 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1830 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 822 | 0.080 |
Why?
|
| Species Specificity | 1 | 2009 | 551 | 0.070 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 235 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2009 | 586 | 0.070 |
Why?
|
| Immunologic Memory | 1 | 2009 | 190 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 439 | 0.070 |
Why?
|
| Comorbidity | 1 | 2012 | 1531 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2012 | 1027 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 1001 | 0.070 |
Why?
|
| Transposition of Great Vessels | 2 | 2018 | 132 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5166 | 0.060 |
Why?
|
| Aorta | 2 | 2021 | 545 | 0.060 |
Why?
|
| Age Factors | 1 | 2012 | 2824 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2005 | 244 | 0.060 |
Why?
|
| Immunization | 1 | 2005 | 308 | 0.060 |
Why?
|
| Vaccination | 1 | 2009 | 962 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2018 | 8259 | 0.050 |
Why?
|
| Cytokines | 1 | 2009 | 1288 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 3415 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 6318 | 0.050 |
Why?
|
| Dobutamine | 1 | 2021 | 56 | 0.040 |
Why?
|
| Middle Aged | 2 | 2012 | 26807 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 4418 | 0.040 |
Why?
|
| Heart Failure | 1 | 2012 | 2298 | 0.040 |
Why?
|
| Risk Factors | 1 | 2012 | 10287 | 0.040 |
Why?
|
| Heart Valves | 1 | 2018 | 51 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2023 | 2175 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 335 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12290 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 377 | 0.030 |
Why?
|
| Heart Rate | 1 | 2018 | 592 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 438 | 0.030 |
Why?
|
| Aged | 1 | 2012 | 19728 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2018 | 851 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 1397 | 0.030 |
Why?
|
| Heart | 1 | 2018 | 731 | 0.030 |
Why?
|
| Mice | 1 | 2009 | 17736 | 0.020 |
Why?
|
| Animals | 1 | 2009 | 34298 | 0.020 |
Why?
|
| Hepatitis A Antigens | 1 | 2005 | 2 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 2005 | 12 | 0.020 |
Why?
|
| Tetanus Toxin | 1 | 2005 | 26 | 0.020 |
Why?
|
| Hepatitis A | 1 | 2005 | 32 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 2005 | 30 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2005 | 140 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2005 | 204 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2005 | 185 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2005 | 266 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 153 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2005 | 325 | 0.010 |
Why?
|
| Hepatitis B | 1 | 2005 | 161 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2005 | 263 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2005 | 533 | 0.010 |
Why?
|